Vaishnu Suresh Kumar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Vaishnu Suresh Kumar has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Anandaram Sreekanth
Department of Chemistry, National Institute of Technology, Tiruchirappalli, India
6 shared publications - Mohit Garg
Department of Chemical Engineering Birla Institute of Technology and Science (BITS) Pilani Rajasthan India
6 shared publications - Jebiti Haribabu
Facultad de Medicina, Universidad de Atacama, Los Carreras 1579, 1532502 Copiapo, Chile
5 shared publications Puthiyavalappil Rasin
Department of Chemistry, Sreenidhi University, Hyderabad – 501301, India
5 shared publicationsVipin Manakkadan
Department of Chemistry, National Institute of Technology, Tiruchirappalli, 620015, Tamil Nadu, India
5 shared publicationsNattamai Bhuvanesh
Department of Chemistry, Texas A & M University, College Station, TX 77842, USA
3 shared publications
Latest Publications
- Open Access
- 11 November 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (49) , 66071-66108
Tailoring compatibility, morphology, and functional properties of polyester-based biodegradable blends: a review
Linking thermodynamic understanding with morphology and compatibilization strategies is essential for designing biodegradable polyester blends that balance performance, processability, and end-of-life degradability.
- 11 November 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (49) , 66071-66108
Open AccessTailoring compatibility, morphology, and functional properties of polyester-based biodegradable blends: a review
Linking thermodynamic understanding with morphology and compatibilization strategies is essential for designing biodegradable polyester blends that balance performance, processability, and end-of-life degradability.
- Open Access
- 7 August 2026
- Published by Elsevier in SSRN Electronic Journal
Exploring the pharmacological potential of Lopinavir analogues for Nipah viral infection using in silico methods
Nipah virus, a highly virulent zoonotic virus, triggers fatal encephalitis and high mortality; however, specific antiviral treatment is not yet effective against this virulent virus. Repurposing drugs provide a prompt method to identify the antiviral potential of compounds against Nipah virus. The current study employed a computational approach on twenty-eight structural analogues, based on Lopinavir, as effective antivirals targeting Nipah virus envelope glycoprotein (NiV-G; PDB ID: 2VSM) and its possible inhibitors for treating Nipah virus infection. The outcomes of molecular docking studies confirmed high binding capacity and better binding affinity of some compounds with respect to their parent compound, Lopinavir, with binding affinity lying between -3.65 to -7.01 kcal/mol. The docking study outcomes reflect a high potential of selected compounds as possible drugs for Nipah virus treatment; further, the molecular dynamics study validated the structural stability of the target protein after binding with the selected compounds, as evident by persistent patterns of RMSD, RMSF, and Radius of Gyration throughout 150 ns simulation time, suggesting a high possibility of its effective antiviral function against Nipah virus infection, whereas its pharmacokinetic and drug-likeness study results revealed acceptable ADMET characteristics of selected compounds, leading towards possible effective treatment of Nipah virus infection. In Conclusion, our findings indicate that selected Lopinavir derivatives represent promising lead candidates for further experimental validation against Nipah virus.
- 7 August 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessExploring the pharmacological potential of Lopinavir analogues for Nipah viral infection using in silico methods
Nipah virus, a highly virulent zoonotic virus, triggers fatal encephalitis and high mortality; however, specific antiviral treatment is not yet effective against this virulent virus. Repurposing drugs provide a prompt method to identify the antiviral potential of compounds against Nipah virus. The current study employed a computational approach on twenty-eight structural analogues, based on Lopinavir, as effective antivirals targeting Nipah virus envelope glycoprotein (NiV-G; PDB ID: 2VSM) and its possible inhibitors for treating Nipah virus infection. The outcomes of molecular docking studies confirmed high binding capacity and better binding affinity of some compounds with respect to their parent compound, Lopinavir, with binding affinity lying between -3.65 to -7.01 kcal/mol. The docking study outcomes reflect a high potential of selected compounds as possible drugs for Nipah virus treatment; further, the molecular dynamics study validated the structural stability of the target protein after binding with the selected compounds, as evident by persistent patterns of RMSD, RMSF, and Radius of Gyration throughout 150 ns simulation time, suggesting a high possibility of its effective antiviral function against Nipah virus infection, whereas its pharmacokinetic and drug-likeness study results revealed acceptable ADMET characteristics of selected compounds, leading towards possible effective treatment of Nipah virus infection. In Conclusion, our findings indicate that selected Lopinavir derivatives represent promising lead candidates for further experimental validation against Nipah virus.
- Open Access
- 22 September 2025
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 7 (19) , 12897-12911
Computational Design of Isomeric Naphthalenediimide–Naphthodithiophene (NDI–NDT) Copolymers for Organic Electronics
- 22 September 2025
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 7 (19) , 12897-12911
Open AccessComputational Design of Isomeric Naphthalenediimide–Naphthodithiophene (NDI–NDT) Copolymers for Organic Electronics
- 4 June 2025
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 49 (26) , 11531-11547
Functionalized nitro-piperonal thiosemicarbazone based ruthenium( ii )–arene complexes for DNA interaction, anticancer and flow cytometry studies
Functionalized thiosemicarbazones derived from 6-nitro piperonal and their corresponding Ru(II)–(η6-benzene) (RuBNPT, RuBNMT, RuBNCT and RuBNMeT)/(η6-p-cymene) (RuPNPT, RuPNMT, RuPNCT and RuPNMeT) complexes were synthesized and explored for their biological efficacy and anticancer potential. The impact on the complexes’ electronic characteristics, coordination affinity, and bioactivity of the piperonal substitution at the N(4)-position with morpholine (6NMT), pyrrolidine (6NPT), cyclohexyl (6NCT), and N-methyl (6NMeT) groups were investigated. Comprehensive characterization using UV-vis, FT-IR, NMR (1H and 13C), HRMS, and XRD (6NPT and RuPNMT) confirmed the structural integrity of the synthesized compounds. Density functional theory (DFT) calculations revealed insights into electronic and physicochemical properties, while molecular docking studies demonstrated effective binding with the EGFR, suggesting their potential as anticancer agents. DNA and BSA binding studies indicated intercalative and hydrophobic interactions, with RuPNMT exhibiting moderate binding affinity. Cytotoxicity assays, including MTT assay results, indicated the strong activity of the RuPNMT and RuPNPT compounds (RuPNMT and RuPNPT exhibited IC50 values of 10.5 μM and 27.2 μM, respectively, in MDA-MB-231 cells, and 24.6 μM and 58.1 μM in MCF-7 cells). Additionally, apoptosis studies were conducted on these compounds using AO–EB staining and flow cytometry. The presence of heteroatoms and planarity of the N(4)-substituent enhanced the bioactivity of the ligands, while coordination with Ru(II)–arene precursors further amplified their effectiveness. This study underscores the effectiveness of these complexes as promising agents for targeted cancer treatment.
- 4 June 2025
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 49 (26) , 11531-11547
Functionalized nitro-piperonal thiosemicarbazone based ruthenium( ii )–arene complexes for DNA interaction, anticancer and flow cytometry studies
Functionalized thiosemicarbazones derived from 6-nitro piperonal and their corresponding Ru(II)–(η6-benzene) (RuBNPT, RuBNMT, RuBNCT and RuBNMeT)/(η6-p-cymene) (RuPNPT, RuPNMT, RuPNCT and RuPNMeT) complexes were synthesized and explored for their biological efficacy and anticancer potential. The impact on the complexes’ electronic characteristics, coordination affinity, and bioactivity of the piperonal substitution at the N(4)-position with morpholine (6NMT), pyrrolidine (6NPT), cyclohexyl (6NCT), and N-methyl (6NMeT) groups were investigated. Comprehensive characterization using UV-vis, FT-IR, NMR (1H and 13C), HRMS, and XRD (6NPT and RuPNMT) confirmed the structural integrity of the synthesized compounds. Density functional theory (DFT) calculations revealed insights into electronic and physicochemical properties, while molecular docking studies demonstrated effective binding with the EGFR, suggesting their potential as anticancer agents. DNA and BSA binding studies indicated intercalative and hydrophobic interactions, with RuPNMT exhibiting moderate binding affinity. Cytotoxicity assays, including MTT assay results, indicated the strong activity of the RuPNMT and RuPNPT compounds (RuPNMT and RuPNPT exhibited IC50 values of 10.5 μM and 27.2 μM, respectively, in MDA-MB-231 cells, and 24.6 μM and 58.1 μM in MCF-7 cells). Additionally, apoptosis studies were conducted on these compounds using AO–EB staining and flow cytometry. The presence of heteroatoms and planarity of the N(4)-substituent enhanced the bioactivity of the ligands, while coordination with Ru(II)–arene precursors further amplified their effectiveness. This study underscores the effectiveness of these complexes as promising agents for targeted cancer treatment.
- 1 August 2024
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 7 (8) , 5622-5639
Biomolecular Interactions and Anticancer Mechanisms of Ru(II)-Arene Complexes of Cinnamaldehyde-Derived Thiosemicarbazone Ligands: Analysis Combining In Silico and In Vitro Approaches
Our study focuses on synthesizing and exploring the potential of three N-(4) substituted thiosemicarbazones derived from cinnamic aldehyde, alongside their Ru(II)-(η6 -p-cymene)/(η6-benzene) complexes. The synthesized compounds were comprehensively characterized using a range of analytical techniques, including FT-IR, UV-visible spectroscopy, NMR (1H, 13C), and HRMS. We investigated their electronic and physicochemical properties via density functional theory (DFT). X-ray crystal structures validated structural differences identified by DFT. Molecular docking predicted promising bioactivities, supported by experimental observations. Notably, docking with EGFR suggested an inhibitory potential against this cancer-related protein. Spectroscopic titrations revealed significant DNA/BSA binding affinities, particularly with DNA intercalation and BSA hydrophobic interactions. RuPCAM displayed the strongest binding affinity with DNA (Kb = 6.23 × 107 M-1) and BSA (Kb = 9.75 × 105 M-1). Assessed the cytotoxicity of the complexes on cervical cancer cells (HeLa), and breast cancer cells (MCF-7 and MDA-MB 231), revealing remarkable potency. Additionally, selectivity was assessed by examining MCF-10a normal cell lines. The active complexes were found to trigger apoptosis, a vital cellular process crucial for evaluating their potential as anticancer agents utilizing staining assays and flow cytometry analysis. Intriguingly, complexation with Ru(II)-arene precursors significantly amplified the bioactivity of thiosemicarbazones, unveiling promising avenues toward the creation of powerful anticancer agents.
- 1 August 2024
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 7 (8) , 5622-5639
Biomolecular Interactions and Anticancer Mechanisms of Ru(II)-Arene Complexes of Cinnamaldehyde-Derived Thiosemicarbazone Ligands: Analysis Combining In Silico and In Vitro Approaches
Our study focuses on synthesizing and exploring the potential of three N-(4) substituted thiosemicarbazones derived from cinnamic aldehyde, alongside their Ru(II)-(η6 -p-cymene)/(η6-benzene) complexes. The synthesized compounds were comprehensively characterized using a range of analytical techniques, including FT-IR, UV-visible spectroscopy, NMR (1H, 13C), and HRMS. We investigated their electronic and physicochemical properties via density functional theory (DFT). X-ray crystal structures validated structural differences identified by DFT. Molecular docking predicted promising bioactivities, supported by experimental observations. Notably, docking with EGFR suggested an inhibitory potential against this cancer-related protein. Spectroscopic titrations revealed significant DNA/BSA binding affinities, particularly with DNA intercalation and BSA hydrophobic interactions. RuPCAM displayed the strongest binding affinity with DNA (Kb = 6.23 × 107 M-1) and BSA (Kb = 9.75 × 105 M-1). Assessed the cytotoxicity of the complexes on cervical cancer cells (HeLa), and breast cancer cells (MCF-7 and MDA-MB 231), revealing remarkable potency. Additionally, selectivity was assessed by examining MCF-10a normal cell lines. The active complexes were found to trigger apoptosis, a vital cellular process crucial for evaluating their potential as anticancer agents utilizing staining assays and flow cytometry analysis. Intriguingly, complexation with Ru(II)-arene precursors significantly amplified the bioactivity of thiosemicarbazones, unveiling promising avenues toward the creation of powerful anticancer agents.
- 4 March 2024
- Published by Elsevier in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
- Vol. 313, 124117
Copper-mediated cyclization of thiosemicarbazones leading to 1,3,4-thiadiazoles: Structural elucidation, DFT calculations, in vitro biological evaluation and in silico evaluation studies
- 4 March 2024
- Published by Elsevier in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
- Vol. 313, 124117
Copper-mediated cyclization of thiosemicarbazones leading to 1,3,4-thiadiazoles: Structural elucidation, DFT calculations, in vitro biological evaluation and in silico evaluation studies
- 1 December 2023
- Published by Bentham Science Publishers Ltd. in Current Analytical Chemistry
- Vol. 19 (10) , 693-703
Fluorescent Materials for Latent Fingerprint Detection
This review provides a comprehensive examination of the application of fluorescence materials for the detection of latent fingerprints in forensic sciences. Traditional methods like powder dusting, cyanoacrylate fuming, chemical methods, and small particle reagent techniques have shown limitations due to issues like low contrast, sensitivity, selectivity, and high toxicity. To overcome these drawbacks, recent focus has shifted towards using fluorescent materials, owing to their unique optical and chemical properties. This review underscores the importance of latent fingerprint development employing metal nanoparticles, semiconductor nanoparticles, and organic fluorescence compounds. These advanced materials not only provide heightened contrast, sensitivity, and selectivity compared to traditional methods but also manifest diminished toxicity. In essence, the review delivers a methodical survey of these pioneering techniques.
- 1 December 2023
- Published by Bentham Science Publishers Ltd. in Current Analytical Chemistry
- Vol. 19 (10) , 693-703
Fluorescent Materials for Latent Fingerprint Detection
This review provides a comprehensive examination of the application of fluorescence materials for the detection of latent fingerprints in forensic sciences. Traditional methods like powder dusting, cyanoacrylate fuming, chemical methods, and small particle reagent techniques have shown limitations due to issues like low contrast, sensitivity, selectivity, and high toxicity. To overcome these drawbacks, recent focus has shifted towards using fluorescent materials, owing to their unique optical and chemical properties. This review underscores the importance of latent fingerprint development employing metal nanoparticles, semiconductor nanoparticles, and organic fluorescence compounds. These advanced materials not only provide heightened contrast, sensitivity, and selectivity compared to traditional methods but also manifest diminished toxicity. In essence, the review delivers a methodical survey of these pioneering techniques.
- 27 June 2023
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 37 (8)
Exploring the anticancer potential of thiadiazole derivatives of substituted thiosemicarbazones formed via copper‐mediated cyclization
A couple of N‐(4)‐morpholine/pyrrolidine‐substituted thiosemicarbazones (TSCs) of fluorene‐2‐carboxaldehyde (FM and FP), and their corresponding thiadiazoles (TDZs) (CFM and CFP), were synthesized and characterized (elemental analysis, ultraviolet–visible [UV–Visible], Fourier transform infrared [FT‐IR], nuclear magnetic resonance [NMR; 1H & 13C], high‐resolution mass spectrometry [HRMS], and single‐crystal X‐ray diffraction [SCXRD]) for the evaluation of their anticancer potential. The TDZs were obtained unexpectedly and are possibly formed via single‐step metal (copper)‐mediated oxidative cyclizations of the TSCs. The synthesized compounds are fairly stable in phosphate buffer at the biological pH of 7.4. The density functional theory [DFT] studies were performed to predict the optimized structures and physicochemical properties of these compounds. The compounds were further subjected to computational and experimental biomolecular investigations in order to evaluate their anticancer activity in detail. CFM had the most potent activity against human breast adenocarcinoma (MCF‐7) and human urinary bladder (T24) cancer cells, with IC50 values of 12.00 and 24.80 μM, respectively. In contrast, CFM had negligible cytotoxicity (IC50 = 98.70 μM) against kidney epithelial cells extracted from an African green monkey (Vero) normal cells. This outcome was preferable to that of the widely used medicine Cisplatin. Molecular docking studies were performed with the breast cancer protein “cytochrome P450 1A1” (CYP1A1) and bovine serum albumin (BSA) to predict how effectively the compounds bind to the receptor. The ADMET findings suggest that these compounds have considerable drug‐likeness and oral bioavailability. These insights may open the door for additional medical research into the bioactivities of TSCs and TDZs produced from bioactive carbonyl compounds.
- 27 June 2023
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 37 (8)
Exploring the anticancer potential of thiadiazole derivatives of substituted thiosemicarbazones formed via copper‐mediated cyclization
A couple of N‐(4)‐morpholine/pyrrolidine‐substituted thiosemicarbazones (TSCs) of fluorene‐2‐carboxaldehyde (FM and FP), and their corresponding thiadiazoles (TDZs) (CFM and CFP), were synthesized and characterized (elemental analysis, ultraviolet–visible [UV–Visible], Fourier transform infrared [FT‐IR], nuclear magnetic resonance [NMR; 1H & 13C], high‐resolution mass spectrometry [HRMS], and single‐crystal X‐ray diffraction [SCXRD]) for the evaluation of their anticancer potential. The TDZs were obtained unexpectedly and are possibly formed via single‐step metal (copper)‐mediated oxidative cyclizations of the TSCs. The synthesized compounds are fairly stable in phosphate buffer at the biological pH of 7.4. The density functional theory [DFT] studies were performed to predict the optimized structures and physicochemical properties of these compounds. The compounds were further subjected to computational and experimental biomolecular investigations in order to evaluate their anticancer activity in detail. CFM had the most potent activity against human breast adenocarcinoma (MCF‐7) and human urinary bladder (T24) cancer cells, with IC50 values of 12.00 and 24.80 μM, respectively. In contrast, CFM had negligible cytotoxicity (IC50 = 98.70 μM) against kidney epithelial cells extracted from an African green monkey (Vero) normal cells. This outcome was preferable to that of the widely used medicine Cisplatin. Molecular docking studies were performed with the breast cancer protein “cytochrome P450 1A1” (CYP1A1) and bovine serum albumin (BSA) to predict how effectively the compounds bind to the receptor. The ADMET findings suggest that these compounds have considerable drug‐likeness and oral bioavailability. These insights may open the door for additional medical research into the bioactivities of TSCs and TDZs produced from bioactive carbonyl compounds.